We are inside the 30 day window IMO for -011 P3 results
Given the trend OGXI should trade up to around $15/$16 whick equates to around a $250M MKT CAP
I'm in the $40 camp on positive P3 results because cancer has been a Hot biotech subsector and -011 has the potential to be a $1B drug. Chemo is never going to go away as a significant treatment for prostate cancer.
Sooner or later during a patients treatment cycle they will be on chemo thats what some sell-side analyst don't understand. I can see a variety of multiple drug cocktails that include -011
ASCO -011 presentation on P3 results no doubt a late breaking poster.
We get 427 results most likely June/July
Institutions will be loading up and their is only a small float